Results 11 to 20 of about 621 (166)

PuraStat RADA16 Self-Assembling Peptide Reduces Postoperative Abdominal Adhesion Formation in a Rabbit Cecal Sidewall Injury Model [PDF]

Frontiers in Bioengineering and Biotechnology, 2021
Objective: To evaluate the effect of PuraStat (2.5% RADA16) administration on postoperative abdominal adhesion formation in an in vivo model.Methods: Anesthetized New Zealand white rabbits underwent cecal sidewall abrasion surgery in which the cecal ...
Eun Seok Gil, Elton Aleksi, Lisa Spirio
doaj   +5 more sources

Impact of Using Self-Assembling Peptide (PuraStat) on Anastomotic Ulcers-A Multicenter Case Series. [PDF]

ACG Case Rep J
Treatment of anastomotic ulcers, also known as marginal ulcers, is challenging, especially when established techniques have failed. PuraStat is a biocompatible synthetic peptide gel that is indicated for hemostasis of bleeding in the gastrointestinal ...
Oza VM, Mittal N, Winchester C, Fazel Y, Manvar A, Goodman A, Girotra M, Khara HS, Kothari S, Kothari TH.   +9 more
europepmc   +5 more sources

Cystoscopic application of PuraStat^® in the treatment of radiation-induced haemorrhagic cystitis. [PDF]

Ann R Coll Surg Engl
The use of radiotherapy has increased in recent years, especially for pelvic neoplasms, and this can result in long-term complications such as recurrent haemorrhagic radiation cystitis (RHC).
Darwazeh H, Hemsworth L, Smith L, Ilie PC.   +3 more
europepmc   +5 more sources

Response to comment on "PuraStat for gastrointestinal bleeding management: Effective approach for endoscopic prevention and rescue therapy" [PDF]

Endoscopy International Open
Roberta Maselli, Leonardo Da Rio, Cesare Hassan, Alessandro Repici   +3 more
doaj   +5 more sources

PuraStat in gastrointestinal bleeding: results of a prospective multicentre observational pilot study [PDF]

Surgical Endoscopy, 2021
Abstract Background A recently developed haemostatic peptide gel for endoscopic application has been introduced to improve the management of gastrointestinal bleeding. The aim of this pilot study was to evaluate the feasibility, safety, efficacy and indication profiles of PuraStat in a clinical setting.
Federica Branchi, Rolf D. Klingenberg-Noftz, Kristina Friedrich, Nataly Bürgel, S Daum, Juliane Buchkremer, Elena Sonnenberg, Michael Schümann, Christoph Treese, Hanno Tröger, Donata Lissner, Hans–Jörg Epple, Britta Siegmund, Andrea Stroux, Andreas Adler, Winfried Veltzke-Schlieker, Daniel Autenrieth, Silke Leonhardt, Andréas Fischer, Christian Jürgensen, Ulrich‐Frank Pape, Bertram Wiedenmann, O Möschler, Maximilian Schreiner, Mathias Z. Strowski, Volkmar Hempel, Yvonne Huber, Helmut Neumann, Christian Bojarski   +28 more
core   +10 more sources

Rapidly Progressive Coexistence of Gastric Antral Vascular Ectasia (GAVE) and Portal Hypertensive Gastropathy (PHG) Presenting With Iron Deficiency Anaemia: Successful Use of PuraStat in a Patient With Implantable Cardioverter-Defibrillator (ICD). [PDF]

Cureus
Gastric antral vascular ectasia (GAVE), or "watermelon stomach", is an uncommon but important cause of chronic gastrointestinal blood loss and iron deficiency anaemia (IDA).
Alafifi M, Shata M, Heiba K, Emara A.
europepmc   +4 more sources

Clip Closure and PuraStat for Prevention of Clinically Significant Delayed Bleeding after Colorectal Endoscopic Submucosal Dissection: A Prospective, Observational Study [PDF]

Gastroenterology Insights
Background and aims. Clinically significant delayed bleeding (CSDB) may complicate endoscopic colorectal submucosal dissection (ESD). We aimed to assess the efficacy of preventive measures for CSDB. Methods.
Mihai Ciocîrlan, Dana Bilous, Andrei Gîla, Daniel-Corneliu Leucuta, Daniela Mihailă, Adrian Tulin, Anca Gheorghiu, Elena Tianu, Cătălina Vlăduț   +8 more
doaj   +5 more sources

A case of gastric antral vascular ectasia in which PuraStat, a novel self‐assembling peptide hemostatic hydrogel, was effective

DEN Open, 2023
Gastric antral vascular ectasia (GAVE) is a gastric hemorrhagic disease associated with chronic liver disease. Argon plasma coagulation is widely used to control gastrointestinal bleeding due to GAVE.
Yoshitsugu Misumi, Miharu Takeuchi, Maiko Kishino, Yoshimichi Kudo, Kouichi Nonaka   +4 more
doaj   +3 more sources

Efficacy of PuraStat hemostatic gel for pulsating arterial bleeding during colorectal endoscopic submucosal dissection [PDF]

Digestive Endoscopy, 2023
ELECTROSURGICAL COAGULATION IS widely used for hemostasis during colorectal endoscopic submucosal dissection (ESD). However, its excessive application can cause thermal injury to deeper layers, leading to peritonitis or post-ESD coagulation syndrome ...
Taishi Okumura, Kenichiro Imai, Kinichi Hotta   +2 more
semanticscholar   +4 more sources

Emergency Endoscopic Hemostasis for Gastrointestinal Bleeding Using a Self-Assembling Peptide: A Case Series [PDF]

Medicina, 2023
Background and Objectives: A novel synthetic self-assembling peptide, PuraStat, has been introduced as a hemostatic agent. This case series aimed to evaluate the clinical efficacy of PuraStat for gastrointestinal bleeding during emergency endoscopy ...
Takashi Murakami, Eiji Kamba, Keiichi Haga, Yoichi Akazawa, Hiroya Ueyama, Tomoyoshi Shibuya, Mariko Hojo, Akihito Nagahara   +7 more
doaj   +3 more sources